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ABSTRACT
Background: Overweight and obesity are increasing in young
adults. However, moderate energy restriction aimed at lowering
body weight may promote bone turnover and bone loss. Inclusion of
fish or fish oils in a weight-loss diet may attenuate these adverse
skeletal effects.
Objective: We examined the effects of incorporating fish or fish oil
into an energy-restricted diet on bone turnover markers in young
overweight adults.
Design: While following a strict hypoenergetic (30% relative to
estimated requirements) diet for 8 wk, 276 overweight men and
women [body mass index (in kg/m2): 27.5–32.5; age: 20–40 y) were
randomly assigned to 1 of 4 dietary groups: sunflower-oil capsules
(3 g/d; control), cod (3  150 g/wk), salmon (3  150 g/wk), and
fish-oil capsules (3 g/d). Body weight, bone biomarkers, and 25-
hydroxyvitamin D were measured at baseline and endpoint. Data
were analyzed with repeated-measures analysis of variance and gen-
eral linear models.
Results: The mean (SD) weight loss was 5.14 3.0 kg (5.8%
3.2% body weight) during the 8 wk in the 4 dietary groups combined.
Urinary N-telopeptides of type I collagen and serum C-terminal
telopeptide of type I collagen increased (P 0.05), whereas serum
osteocalcin (but not bone-specific alkaline phosphatase) decreased
(P  0.05) from baseline to endpoint. Increased fish or fish-oil
consumption had no effect (P 0.1) on the changes in bone markers
induced by weight loss. In contrast, increased salmon consumption
increased serum 25-hydroxyvitamin D (P 0.01).
Conclusions: A nutritionally adequate but energy-restricted diet,
with different contents of n3 fatty acids, which resulted in modest
weight loss, unfavorably altered bone turnover markers in young
overweight adults. Such changes were not prevented by increased
fish or fish-oil consumption. This trial was registered at the US
National Library of Medicine as #NCT00315770. Am J Clin
Nutr 2008;87:1045–52.
INTRODUCTION
Obesity is a major public health concern because it is im-
plicated in the development of many chronic diseases (1–3).
However, in relation to skeletal health, increased body weight
in postmenopausal women is thought to reduce the risk of
osteoporosis (4 – 6). For example, annual bone loss was ob-
served to be significantly lower in postmenopausal women
with a higher body mass index [BMI (in kg/m2):25] than in
postmenopausal women with a lower BMI (25) (7). Fur-
thermore, weight loss is associated with increased risk of hip
fracture in older women and men (8, 9). Even moderate weight
loss may increase the rate of bone resorption (10 –11) and
accelerate bone loss (10 –13) in overweight and obese post-
menopausal women. Some studies (14 –16), but not all (17,
18), have shown increased bone loss after weight reduction in
premenopausal women, whereas the effects of energy restric-
tion on bone turnover in overweight men has apparently not
received much attention (19). Indeed, the effect of energy
restriction and accompanying weight loss on skeletal health in
young to mid adulthood is still unclear.
Some evidence suggests that the adverse effects of energy
restriction on bone turnover may be mitigated by increasing
calcium intakes (up to 1.7 g/d) in overweight postmeno-
pausal women (10, 12). Such calcium intakes, however, are
rarely achieved by dietary means (20, 21). Increased fish
consumption is often conducive to a healthy diet, and intake of
2 servings/wk (preferably fatty fish) is recommended by the
American Heart Association for healthy adults (22). Recently,
we showed that including seafood in energy-restricted diets
can increase weight loss (23). Fatty fish such as salmon are
rich in n3 fatty acids, and increased fish consumption as part
of a weight-loss diet was observed to be more effective in
improving glucose-insulin metabolism and dyslipidemia in
overweight hypertensive subjects than weight loss alone (24).
n3 Fatty acids were shown to stimulate intestinal calcium
absorption and beneficially to alter bone metabolism in rat and
cell model systems (25–28). In this context, van Papendorp et
al (29) showed, in a randomized trial with 40 osteoporotic
patients, that subjects taking a supplement rich in marine-
based n3 fatty acids or these n3 fatty acids together with
evening primrose oil had a greater efficiency of intestinal
calcium absorption and higher concentrations of markers of
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bone formation than did subjects taking the placebo. Further-
more, a high ratio of n6 to n3 fatty acids in the diet is
associated with low bone mineral density (BMD) at the hip in
men and women  45 y (30). Although there has been much
less investigation of the effect of whole fish on calcium and
bone metabolism, Zalloua et al (31) recently reported that
increased seafood consumption is significantly associated
with increased BMD in women, aged 25– 64 y. Thus, in-
creased fish and fish-oil consumption may attenuate the effect
of energy restriction-induced weight loss on bone turnover,
although this has not been studied. Therefore, the hypothesis
of this study was that moderate weight loss, arising from
dietary energy restriction, would induce an increase in the rate
of bone turnover in young overweight adult men and women
and that possibly the inclusion of more fish or fish oil in the
diet would ameliorate these negative effects of weight loss on
bone turnover.
SUBJECTS AND METHODS
Subjects
A total of 324 young adults were recruited into the SEA-
FOODplus YOUNG study, which was an 8-wk intervention
study of dietary-based weight loss with or without increased
consumption of fish or fish oil. The trial was conducted at 3
centers, Iceland (n140), Spain (n120), and Ireland (n64),
during the months of October 2004 through May 2005. The
progress of these subjects through the trial is shown in Figure 1.
Details of the subjects were reported previously (23). In brief,
inclusion criteria included age 20–40 y, BMI between 27.5 and
32.5, waist circumference minimum of 80 cm (women) and 94
cm (men), and being weight stable within the 3 mo preceding the
trial. Volunteers were excluded if they consumed supplements
that contained calcium, vitamin D, or fish oil within the previous
3 mo or during the study. Drug treatment of diabetes mellitus; the
taking of other prescribed medications, including antiinflamma-
tory and antihypertensive drugs; pregnancy or lactation; drug or
alcohol abuse; vegetarianism; dislike of fish; and professional
athletes were also reasons for exclusion. The study was approved
by the appropriate ethics committee in each collaborating center,
and all participants gave their written consent according to the
Helsinki Declaration.
Study design
Full details of the study design were reported previously
(23). Each subject was instructed to follow a diet, energy
restricted by 30% from estimated energy requirement (600
kcal/d; range: 473–718 kcal/d) for 8 consecutive weeks. The
energy deficit for each subject was calculated on the basis of
their estimated basal metabolic rate (with the use of Harris-
Benedict equations), including a correction factor for the
overweight status of the subject, and adjusting for physical
activity level (set at 1.3), as outlined previously (23). The
subjects were randomly assigned to 4 diets with varying di-
etary protein source and amount of n3 fatty acids: 1) no
seafood [control; included 6 sunflower-oil capsules/d; Loders
Croklaan (Lipid Nutrition), Wormerveer, Netherlands; en-
capsulated by Banner Pharmacaps, Tilburg, Netherlands], 2)
lean fish cod (150 g cod 3/wk; Samherji, Iceland), 3) salmon
(150 g salmon 3/wk; Marine Harvest, Nutreco, Norway), or
4) fish-oil capsules [3 g/d; 6 capsules/d; Loders Croklaan
(Lipid Nutrition); encapsulated by Banner Pharmacaps].
These 4 groups allowed us to differentiate between a fish and
fish-oil effect on bone turnover. The daily provision of n3
fatty acid was 0.001 g, 0.3 g, 3.0 g, and 1.5 g for the sunflower-
oil, cod, salmon, and fish-oil diets, respectively.
To achieve a weight loss of 0.5–1 kg/wk, a 30% energy-
deficient diet was formulated by a trained nutritionist for each
subject on an individual basis, as described previously (23). In
brief, similar diets were formulated for each of the 4 treatment
groups and incorporated the particular dietary intervention. All
diets were approximately matched across the 4 groups for total
fat (30–35% of total energy), carbohydrate (50–55% of total
energy), protein (16–20% of total energy), and dietary fiber
(20–25 g), and we aimed that each intervention diet would meet
the dietary recommendations for macro- and micronutrient in-
takes. These energy-restricted diets contained similar sources of
fruit, vegetables, dairy products, and meat. An exchange list was
also formulated to offer a variety of substitute foods of similar
caloric content and nutrient composition.
324 Randomly
assigned
80 Control
[15, Ireland; 30, Spain; 
35, Iceland] 
Dropouts = 14
80 Cod
[16, Ireland; 29, Spain; 
35, Iceland] 
Dropouts = 10
80 Fish oil
[14, Ireland; 31, Spain; 
35, Iceland] 
Dropouts = 12
70 Endpoint laboratory 
data obtained
84 Salmon
[19, Ireland; 30, Spain; 
35, Iceland] 
Dropouts = 10
66 Endpoint laboratory 
data obtained
74 Endpoint laboratory 
data obtained
66 Endpoint laboratory 
data obtained* 
FIGURE 1. Flow of subjects in the study. *One subject completed the study but failed to provide a blood sample; data from 1 subject was excluded because
bone turnover marker concentrations were well outside the normal range.
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During the intervention phase, each subject made 3 visits to the
study center, at baseline (week 0), midpoint (week 4), and end-
point (week 8). In addition, in weeks 2 and 6 subjects were
contacted by phone or email by the nutritionist to encourage
further compliance with the intervention. The subjects were also
encouraged to contact the clinic or metabolic unit on their own
initiative if they had any questions about the research during the
8-wk intervention period. A fasting blood sample was drawn and
a urine sample was collected at baseline and endpoint. Systolic
and diastolic blood pressures were measured at baseline and
endpoint with the use of the Medisana blood pressure monitor
(Medisana AG, Germany; www.medisana.de).
Anthropometry and lifestyle data
Anthropometrics and body composition by bioimpedance
analysis were measured at baseline, midpoint, and endpoint, as
described previously (23). Subjects also answered a health and
lifestyle questionnaire at baseline and endpoint, which assessed
physical activity, general health, smoking status, and alcohol
consumption. Subjects were asked to maintain their normal level
of physical activity. Dietary intakes were estimated from 2-d
weighed food records completed before baseline and before end-
point visits (between weeks 5 and 8). The dietary records were
analyzed with the use of the accepted food-nutrient database in
each country. Nutrient intakes in Ireland were calculated with the
use of WISP software (version 3; Tinuviel Software, Llanfechell,
United Kingdom) that uses data from McCance and Widdow-
son’s The Composition of Foods, sixth (32) and fifth (33) edi-
tions, plus supplementalvolumes togeneratenutrient intakedata. In
Iceland, the nutrient-calculating program is ICEFOOD software
(version 2002; Public Health Institute of Iceland, Reykjavik, Ice-
land), designed for the national dietary survey of The Icelandic
Nutrition Council (34), with the use of the National Nutrition
Database ISGEM for calculation of nutrient value in the diet; in
Spain, the MEDISYSTEM (Sanocare, Madrid, Spain) software
was adapted to the Spanish foods. The data were then amalgam-
ated for statistical analysis to describe nutrient intakes.
Compliance with the intervention diets was assessed by the 2-d
weighed food records and by a formerly validated food-
frequency questionnaire for seafood, first in Iceland for young
women and then in a cross-European validation study in Iceland,
Ireland, and Spain for young adults of both sexes (35, 36). The
food-frequency questionnaire was administered at all 3 visits.
Compliance was also assessed by analyzing n3 and n6 fatty
acids in erythrocyte phospholipids in fasting bloods, as reported
elsewhere (23). Results showed good compliance with the inter-
vention diets.
Collection and preparation of samples
Blood was collected by venepuncture into a evacuated tube
with no additive and processed to serum, which was immediately
stored at80 °C until required for analysis. Urine was stored at
20 °C until required for analysis.
Laboratory methods
Serum osteocalcin (OC) and bone-specific alkaline phospha-
tase (BAP) were measured with the use of Metra enzyme immu-
noassay kits (Quidel Corporation, San Diego, CA). Serum
C-terminal telopeptide of type I collagen (CTx) was measured
with the use of the Serum CrossLaps enzyme-linked immunosor-
bent assay (ELISA) kit (Nordic Bioscience Diagnostics A/S,
Denmark). Urinary creatinine concentrations were measured
with the use of a quantitative, colorimetric assay by Metra
(Quidel Corporation). Urinary N-telopeptides of type I collagen
(NTx) was measured by the Osteomark ELISA (Unipath Ltd,
Bedford, United Kingdom). Urinary NTx concentrations were
expressed relative to urinary creatinine concentrations. Serum
25-hydroxyvitamin D [25(OH)D] concentrations were measured
with the use of ELISA (OCTEIA 25-Hydroxy Vitamin D; Im-
muno Diagnostic Systems, Ltd, Boldon, United Kingdom). The
quality and accuracy of the serum 25(OH)D analysis in the cen-
tral biomarker analytic laboratory of the study (University Col-
lege Cork) are assured on an ongoing basis by participation in the
Vitamin D External Quality Assessment Scheme (Charing Cross
Hospital, London, United Kingdom). Serum concentrations of
intact parathyroid hormone (PTH) were measured by ELISA
(OCTEIA intact parathyroid hormone; Immuno Diagnostic Sys-
tems, Ltd). Intraassay variability for serum OC, BAP, CTx,
25(OH)D, and PTH and for urinary NTx and creatinine was
8.1%, 6.2%, 8.4%, 7.8%, 8.6%, 8.3%, and 3.4%, respectively.
Interassay variability in these variables was avoided by analyz-
ing all samples from a subject in the same run.
Statistical analysis
The SEAFOODplus YOUNG intervention study was powered
to detect 1-kg difference in weight loss between the 4 diet
groups, as the primary outcome (23). The sample size completing
the intervention study and included in the present analysis (n
66–74 per group) provided sufficient power to detect a minimum
of a 11.1%, 15.1%, 25.5%, and 30.9% change in the biomarkers
of bone turnover: serum OC, BAP, and CTx and urinary NTx,
respectively, within a group. Ricci et al (11) previously reported
a 12.8%, 36.4%, and 52.5% increase in serum OC, urinary pyr-
idinoline (PYD), and deoxypyridinoline (DPD) (markers of bone
resorption), respectively, after moderate weight loss in post-
menopausal women. The present study used serum CTx and
urinary NTx as markers of bone resorption. Serum markers of
bone resorption were shown to be less variable than urinary-
based markers, which may be related to variability in creatinine
measurement (37). Statistical analysis of the data was conducted
with the use of SPSS for WINDOWS version 12.0 (SPSS Inc,
Chicago, IL). Descriptive statistics (mean, median, and SD) were
determined for all variables. Serum concentrations of the bone
biomarkers were not normally distributed and thus were log
transformed to achieve near-normal distributions. Baseline char-
acteristics of subjects in the different intervention groups were
compared with the use of chi-square test (for male-to-female
ratio), one-factor analysis of variance (ANOVA; for normally
distributed variables), or Kruskal-Wallis test (for nonnormally
distributed variables). Baseline differences in the biochemical
markers of bone turnover, serum 25(OH)D and PTH, across the
4 intervention groups were assessed by ANOVA and analysis of
covariance, adjusting for sex and country. Differences in changes
in nutrient intake from baseline to endpoint across the groups
were tested by ANOVA and Tukey’s tests (for normally distrib-
uted variables) or Kruskal-Wallis test (for nonnormally distrib-
uted variables).
Linear models of the response in a repeated-measures analysis
for the differences in bone marker concentrations, adjusted for
percentage of weight loss, were set up. The main effects included
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were dietary treatment, sex, and country. The linear models also
included 2-factor interactions between the main effects. Regres-
sion analysis was used to examine the association between
weight loss and changes in bone marker concentration (unad-
justed and adjusted for potential confounded effects of sex, coun-
try, and change in dietary intake of bone active nutrients during
the course of the 8-wk intervention). A P value of  0.05 was
taken as being statistically significant.
RESULTS
Two hundred seventy-eight (120 men and 158 women) of the
324 subjects recruited (86%), completed the study (see Figure 1).
The 2 most common reasons for dropout were that the subject
was unable to follow the energy-restricted diet or experienced a
lack of time to maintain the scheduled clinical visits. Dropouts
were equally distributed between intervention groups. For the
current analysis, we had complete dietary and anthropometric
data and pre- and postintervention bone biomarker values for 277
subjects. However, because concentrations of bone turnover
markers in 1 male subject were well outside the normal range,
data from this subject were excluded from our analysis.
Baseline characteristics
The baseline characteristics of subjects across the 4 treatment
groups are shown in Table 1. Across the 4 treatment groups,
there were no significant differences in male-to-female ratio,
mean age, BMI, fat mass, percentage of body fat, and systolic or
diastolic blood pressure. Mean waist circumference and height
were significantly lower (P 0.05) in the fish-oil group than in
the salmon group. Mean hip circumference and body weight
were significantly lower (P 0.05) in the fish-oil group than in
the cod and salmon groups. Dietary intakes of protein, carbohy-
drate, fat, or calories did not differ across the 4 dietary treatment
groups. Similarly, intakes of other bone-regulating nutrients
such as calcium, vitamin D, phosphorus, magnesium, sodium,
and potassium did not differ across the 4 dietary treatment
groups. In addition, there were no significant differences in mean
concentrations of biochemical makers of bone turnover (OC,
BAP, CTx, or NTx), 25(OH)D, or PTH among the 4 dietary
treatment groups at baseline (Table 2).
Nutrient intakes during the intervention period
As expected, energy intakes, as well as absolute intakes of
protein, carbohydrate, and fat, decreased between baseline and
endpoint, and the decreases were similar across the study groups
for energy, carbohydrate, and fat. The mean (SD) decrease in
energy in the sunflower-oil, cod, salmon and fish-oil groups was
902  756, 943  624, 788  834, and 808  630
kcal/d, respectively, with no significant difference among groups
(P  0.27). The mean decrease in protein intake was smaller
(P 0.05) in the salmon group (20.9 28.0 g/d) than that in
TABLE 1
Baseline characteristics of the study participants by treatment group1
Group 1
(n 66)
Sunflower oil
Group 2
(n 70)
Cod
Group 3
(n 74)
Salmon
Group 4
(n 66)
Fish oil P2
Men:women3 24:42 31:39 37:37 26:40 0.405
Age (y) 33 54 32 6 32 5 31 5 0.465
Anthropometric measurements
Waist (cm) 94.5 7.0a,b 96.8 6.8a,b 97.2 7.9a 94.2 6.5b 0.022
Hip (cm) 110.4 4.9a,b 111.1 5.6a 111.0 4.9a 108.7 5.3b 0.023
Height (m) 1.70 0.1a,b 1.72 0.1a,b 1.73 0.1a 1.70 0.1b 0.029
Weight (kg) 86.7 9.3a,b 89.4 9.7a 91.1 11.8a 84.8 9.9b 0.002
BMI (kg/m2) 30.0 1.5 30.2 1.4 30.4 1.4 29.8 1.5 0.062
Fat mass (kg)5 29.5 5.9 29.4 5.8 29.1 5.2 28.1 5.5 0.439
Body fat (%)5 34.5 8.0 33.3 7.6 32.4 7.0 33.4 7.7 0.530
Fat-free mass (kg)5 57.6 11.9 60.0 11.6 62.1 12.4 57.3 11.7 0.059
Blood pressure
Systolic (mm Hg) 126.1 10.4 125.0 12.1 127.8 13.1 123.2 13.2 0.128
Diastolic (mm Hg) 72.8 7.7 73.2 7.9 73.0 7.7 71.1 7.4 0.257
Dietary intake
Energy (kcal/d) 2344 648 2390 658 2276 917 2254 716 0.324
Protein (% of energy intake) 17.5 4.4 16.7 3.6 17.3 4.1 17.5 3.8 0.544
Carbohydrate (% of energy intake) 41.2 8.5 41.7 9.5 41.5 9.5 40.9 10.1 0.920
Fat (% of energy intake) 35.9 7.2 36.3 7.1 35.8 8.1 35.4 7.5 0.952
Calcium (mg/d) 1111 392 1064 408 1084 472 1057 395 0.628
Phosphorus (mg/d) 1683 497 1636 432 1598 545 1586 453 0.534
Magnesium (mg/d) 305 95 307 89 301 106 307 90 0.845
Sodium (mg/d) 3177 1236 3233 1153 3154 1530 2975 1044 0.579
Potassium (mg/d) 3692 4632 3138 919 3112 1156 3093 880 0.828
Vitamin D (g/d) 2.6 2.5 2.9 2.6 3.3 4.4 3.5 4.5 0.915
1 Different superscript letters denote significant (P 0.05) differences in mean values across the 4 groups (by Tukey’s tests).
2 Analyzed with ANOVA or Kruskal-Wallis test for normally and nonnormally distributed data, respectively.
3 Analyzed with chi-square test.
4 x  SD (all such values).
5 Measured by bioelectrical impedance analysis (assessed in 270 subjects).
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the cod (24.9  26.8 g/d), fish-oil (28.2  22.9 g/d), and
sunflower-oil (35.2  35.1 g/d) groups. Mean vitamin D in-
takes decreased from before to after intervention in the
sunflower-oil, cod, and fish-oil groups (by1.0 2.9,1.2
2.8, and 1.9  4.4 g/d, respectively) but increased in the
salmon group (by 7.2 9.6 g/d), a difference between groups
that was significant (P 0.001). Intakes of calcium, phosphorus,
magnesium, sodium, and potassium decreased during the 8 wk to
a similar extent across the 4 treatment groups (P 0.4).
Effect of weight loss and dietary intervention on
biochemical markers of calcium and bone metabolism
The detailed weight-loss findings, as the primary outcomes of
the intervention study, were recently reported in detail elsewhere
(23). In brief, during the 8 wk, 95% of subjects (n  263) lost
weight (0.5 kg) with a mean weight loss of 5.14  3.0 kg
(percentage of weight loss: 5.8% 3.2%). Mean BMI decreased
from 30.1  1.5 to 28.4  1.6. Mean weight loss during 8 wk
across the 4 dietary groups was4.4 2.8,5.3 3.2,5.4
2.7, and 5.5  3.3 kg for the sunflower-oil, fish-oil, cod, and
salmon groups, respectively.
Although weight loss as a result of the caloric deficit lead to
significant changes in the concentrations of biochemical markers
of bone turnover, the inclusion of either lean or fatty fish or fish
oil as part of the energy-restricted diet had no effect on these
biochemical markers (Table 2), even after controlling for poten-
tial confounding effects of sex and country and individual weight
loss during 8 wk. Weight loss arising from the energy-restricted
diet, and irrespective of fish intervention, lead to a significant
reduction in mean concentrations of serum OC (2.2%) (but not
serum BAP) and increases in mean concentrations of serum CTx
(15.7%) and urinary NTx (6.9%) (for P values of main time
effects, see Table 2). No significant interactions were observed
with sex or country, indicating that effects of weight loss on bone
turnover markers were similar across both sexes and across coun-
tries. Serum PTH concentration was unaffected by weight loss or
fish intervention (Table 2). Serum 25(OH)D concentration was
increased by the inclusion of salmon as part of the energy-
restricted diet, but there were no significant effects of the other
treatments on serum 25(OH)D concentration (Table 2). This
finding was not influenced by sex or country.
Regression analysis showed that weight loss during 8 wk was
significantly associated with changes in serum OC (P 0.015),
serum BAP (P  0.004), serum CTx (P  0.024), and urinary
NTx (P 0.0001), even after controlling for possible confound-
ing effects of sex and country. These associations remained after
controlling for changes in intake or status of bone-active nutri-
ents (intakes of calcium, phosphorus, sodium, potassium, pro-
tein, as well as energy, and vitamin D status) from baseline to
endpoint (data not shown).
DISCUSSION
The findings of the present trial, which was novel in its design,
showed that an energy-restricted diet (30% kcal relative to
estimated requirements) for 8 wk lead to significant weight loss
in young overweight adult men and women, which was associ-
ated with alterations in biochemical markers of bone turnover.
Furthermore, the weight-loss-induced increase in the rate of bone
resorption in these young overweight adults was not amelioratedTA
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by inclusion of fish or fish oil in the energy-restricted diet, al-
though salmon intake improved both vitamin D intake and status.
The target weight loss was achieved in the majority of partic-
ipants during the 8-wk period; furthermore, the weight loss
achieved by these adult men and women was comparable with
other studies carried out predominantly in pre- and postmeno-
pausal women (10, 11, 13, 15, 38); however, the present study
had a larger sample size (n 276) than these previous studies. In
addition, it showed a larger weight loss with diets that included
seafood than did a control diet without seafood (23). Also note
that the effect of weight loss on markers of bone resorption in the
present study, although in line with findings of many (10–11, 13,
15) but not all (17, 18) studies of dietary-induced weight loss, was
evident during a shorter time frame (8 wk) with a more moderate
weight loss (5.8%) in our younger adult men and women, aged
20–40 y. For example, Salamone et al (15) reported a modest, but
significant, increase in mean annualized percentage change in
urinary NTx in overweight premenopausal women who had a
weight loss of5.3% during 18 mo, whereas Noakes et al (38),
in their 12-wk weight-loss dietary intervention study, reported
elevated urinary DPD and PYD in obese women, aged 20–65 y,
who lost8.4% body weight, on average.
The lack of effect of weight loss on serum BAP in the present
study is in line with that reported in weight-loss studies of over-
weight postmenopausal women (13) and middle-aged adult men
and women (39), whereas the observed weight-loss-induced de-
crease in serum OC observed in the present study is in contrast to
that reported in other studies, which reported either an increase
(10–13, 38, 40) or no change in serum OC with dietary-induced
weight loss (15, 17, 18, 39). It is possible that the 8-wk interven-
tion in the present study was too short in duration for the increases
in bone resorption to be mirrored by increases in the rate of bone
formation, which would be expected to occur after a lag phase
when the processes of bone resorption and formation are cou-
pled. Generally, the recruitment of osteoblasts occurs6–7 wk
after resorption (41). Ricci et al (11) measured markers of bone
resorption and formation serially during 6 mo in a weight-loss
intervention in postmenopausal women (n  27; mean age:
55.9 y) and only observed a significant increase in serum OC
from week 5 of weight loss (10.2%  5.5%) onward (urinary
PYD and DPD increased significantly after 1 wk). It is not clear
whether the relatively short-term weight-loss-induced changes
in bone turnover markers observed in the present study would be
translated into changes in BMD. However, several studies of
calorie-restricted weight loss have shown an increased rate of
bone resorption or bone turnover, which was accompanied by an
increased rate of bone loss observed in overweight or obese pre-
and postmenopausal women (10–13, 15) and middle-aged men
(19). The effects of dietary-induced weight loss on BMD have yet
to be investigated in adult men and women aged between 20 and
40 y, a group in which overweightness and obesity are on the
increase. Note that obese older women (42) and obese younger
men (43) were reported to have higher BMD values at baseline.
The mechanism(s) by which weight loss induces these
changes in bone metabolism are unclear. Some investigators
have suggested that the bone loss may possibly be due to a
reduction in mechanical stress in the weight-bearing skeleton
during weight loss, which may influence bone remodelling (15).
Others have suggested that reduced calcium intake during
dietary-induced weight loss may contribute to increased bone
mobilization and loss (44). Ricci et al (11) observed an increase
in serum PTH and in markers of bone resorption after a 6-mo
energy-restricted weight-loss intervention, which they suggest
may have been associated with the reduced calcium intakes dur-
ing the period (from 666 to 504 mg/d from baseline to endpoint).
In the present study, mean calcium intakes were relatively high
at baseline (1079 mg/d) and endpoint (851 mg/d), possibly ex-
plaining why serum PTH concentrations were unaffected during
the 8-wk intervention. Although not assessed in the present
study, it was suggested that energy restriction may decrease
calcium absorption [see review by Shapses and Riedt (44)]. A
calorie-restricted diet may have lower concentrations of a num-
ber of other bone-active nutrients, beyond just calcium, which
may have a role in weight-loss-induced elevations in bone turn-
over. However, in the present study, the change in bone markers
associated with weight loss were not ameliorated by controlling
for changes in intakes of a number of bone nutrients, including
calcium, phosphorus, potassium, and protein. Note again, how-
ever, that intakes of these nutrients even in the calorie-restricted
diet were still close to that recommended (45). Thus, it seems that
the weight-loss-induced bone resorption was independent of
changes in nutrient intake. It is also possible that weight reduc-
tion induced the changes in bone metabolism by alternative
means, such as decreases in serum estrogen, leptin, glucagon-
like peptide 2, growth hormone, and insulin-like growth factor I
or increased cortisol, as recently discussed by Shapses and Riedt
(44).
The inclusion of fish as part of a weight-reducing diet was
shown to improve the status of several health biomarkers (23, 46,
47), and there are lines of evidence to suggest that fish and the
n3 fatty acids present in some fish oils may promote calcium
absorption and skeletal health (28–30, 48, 49). In the present
study, consumption of cod, salmon, or fish oil as part of a weight-
reducing diet seemingly had no influence on biomarkers of bone
turnover. Fish oils (as opposed to fish liver oils) and cod fish are
poor sources of vitamin D (50, 51) and therefore were insufficient
to improve 25(OH)D concentrations during the 8 wk in these
study groups, unlike the group that received 3 portions of salmon
per week, in which an increase (8 nmol/L) in mean serum
25(OH)D was observed. Salmon is a rich source of vitamin D
(typically providing 9.6 g/100 g) (50). In addition, this in-
creased dietary intake of vitamin D was likely to have a signif-
icant effect on vitamin D status because of the study being con-
ducted during wintertime when there is no dermal production of
the vitamin (52). The improvement in vitamin D status in the
salmon group however was not translated into effects on bone
marker concentrations or indeed on serum PTH during the 8-wk
intervention. Weight loss per se had no effect on serum 25(OH)D
concentrations in the adults in the present study, in line with
similar findings from other studies (10, 11, 17, 40).
The present study has some limitations, including the absence
of data on BMD and physical activity. In addition, the study was
powered to observe a change in biomarkers of bone turnover
reported from a weight-loss study in postmenopausal women
who had calcium intakes of0.5 g/d (11); therefore, it may have
been underpowered for a young adult population undergoing
weight loss with a calcium intake of 1 g/d. Nevertheless, the
large number of subjects in the current study compared with most
previous studies that examined the effects of weight loss on bone
turnover is one of its strengths.
In conclusion, this study showed that modest weight loss,
achieved by caloric restriction during 8 wk, unfavorably altered
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bone metabolism in overweight 20–40-y-old adult men and
women. The inclusion of fish or fish oil in the diet was unable to
attenuate the effect of weight loss on bone turnover. Against a
background of global increases in body weight in young adults,
the formulation of nutritionally adequate, energy-restricted diets
that do not result in adverse physiologic effects, such as bone
loss, is becoming increasingly important. Further longer-term
investigations are warranted to investigate the effects of weight
loss on bone metabolism and bone mass in overweight and obese
subjects at different life stages and to explore possible dietary
strategies to minimize the effect of weight loss on bone.
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